Glomerular Filtration Rate
Last reviewed: April 2026
Estimate your kidney function with the eGFR calculator. Uses the CKD-EPI 2021 equation with creatinine level, age, and sex to determine kidney disease stage. This calculator runs entirely in your browser — your data stays private, and no account is required.
GFR (Glomerular Filtration Rate) measures how well your kidneys filter waste from the blood, expressed in milliliters per minute. A normal GFR is 90+ mL/min, and values below 60 sustained for three or more months indicate chronic kidney disease (CKD).[1] GFR is estimated (eGFR) from serum creatinine levels using formulas that account for age, sex, and body size — the CKD-EPI equation replaced the older MDRD formula as the standard in 2021 and no longer includes a race coefficient.[2] About 37 million Americans have CKD, with diabetes and hypertension causing approximately 70% of cases. Early detection through routine blood work and GFR monitoring can slow progression significantly through blood pressure control and dietary modifications.[3] Use the Blood Sugar Converter to monitor diabetes-related kidney risk factors.
CKD is classified by GFR: Stage 1 (GFR ≥90, kidney damage with normal function), Stage 2 (60–89, mild decrease), Stage 3a (45–59, mild to moderate), Stage 3b (30–44, moderate to severe), Stage 4 (15–29, severe), and Stage 5 (below 15, kidney failure requiring dialysis or transplant). Stages 1–2 are often asymptomatic and detected only through blood work. Management focuses on controlling blood pressure (target below 130/80), managing diabetes if present, limiting sodium intake, and avoiding nephrotoxic medications (NSAIDs, certain antibiotics). Protein restriction may be recommended in later stages. Monitor related health markers with our Blood Pressure Calculator.
| Stage | GFR (mL/min) | Kidney Function | Action |
|---|---|---|---|
| 1 | 90+ | Normal or high | Monitor, manage risk factors |
| 2 | 60–89 | Mildly decreased | Monitor, lifestyle changes |
| 3a | 45–59 | Mild-moderate decrease | Nephrology referral |
| 3b | 30–44 | Moderate-severe decrease | Active management |
| 4 | 15–29 | Severely decreased | Prepare for dialysis/transplant |
| 5 | <15 | Kidney failure | Dialysis or transplant needed |
Glomerular filtration rate (GFR) measures how effectively your kidneys filter waste products from the blood. Expressed in milliliters per minute per 1.73 square meters of body surface area, GFR is the single most important indicator of kidney health and the primary metric used to stage chronic kidney disease (CKD). A normal GFR ranges from 90–120 mL/min/1.73m² in healthy young adults, declining naturally with age at approximately 1 mL/min/year after age 40.
Direct GFR measurement requires injecting a filtration marker (such as inulin or iothalamate) and measuring its clearance — an expensive, time-consuming procedure reserved for research and transplant evaluation. In clinical practice, GFR is estimated (eGFR) from blood creatinine or cystatin C levels combined with demographic factors. The CKD-EPI 2021 equation, currently recommended by the National Kidney Foundation and American Society of Nephrology, uses serum creatinine, age, and sex — notably removing race as a variable from earlier equations (the 2009 CKD-EPI and MDRD formulas included a race coefficient that systematically overestimated kidney function in Black patients, potentially delaying diagnosis and treatment).
The cystatin C equation provides an alternative when creatinine-based estimates may be unreliable — in patients with extreme muscle mass (bodybuilders, amputees, paralysis patients), those taking creatine supplements, or during acute kidney injury when creatinine levels are rapidly changing. Cystatin C is produced by all nucleated cells at a relatively constant rate, making it less influenced by muscle mass than creatinine. Many nephrologists now use a combined creatinine-cystatin C equation for the most accurate estimation.
Stage 1 (GFR 90+): Kidney damage present (abnormal urinalysis, imaging, or biopsy) but filtration is normal. Often detected incidentally through protein or blood in urine. Focus on identifying and treating the underlying cause (diabetes, hypertension, glomerulonephritis). Stage 2 (GFR 60–89): Mild reduction, often asymptomatic. May be age-appropriate in older adults. Emphasis on risk factor control — blood pressure below 130/80, blood sugar management, avoiding nephrotoxic medications. Stage 3a (GFR 45–59) and 3b (GFR 30–44): Moderate decline. Complications begin appearing — anemia, mineral bone disease, acidosis. Referral to nephrology is typically recommended at Stage 3b. Medication dose adjustments become necessary. Stage 4 (GFR 15–29): Severe reduction. Preparation for renal replacement therapy (dialysis or transplant) begins. Symptoms like fatigue, swelling, nausea, and poor appetite become noticeable. Stage 5 (GFR below 15): Kidney failure. Dialysis or transplant is needed to sustain life. Uremic symptoms (confusion, severe nausea, pericarditis) develop without treatment.
Dietary intake: Eating a large protein meal (especially cooked meat) within 12 hours before a blood draw can temporarily elevate creatinine by 10–30%, falsely lowering estimated GFR. Creatine supplements have the same effect. Hydration status: Dehydration concentrates creatinine, reducing eGFR estimates. Overhydration dilutes it, inflating estimates. Medications: Trimethoprim, cimetidine, and some HIV antiretrovirals block creatinine secretion in the kidney tubules, raising serum creatinine without actually reducing kidney function — creating falsely low eGFR readings. Always inform your physician about all medications before interpreting results.
For patients with early CKD (Stages 1–3a), evidence-based interventions that slow progression include blood pressure control (target below 130/80 using ACE inhibitors or ARBs, which provide kidney-specific protection), SGLT2 inhibitors (medications like dapagliflozin and empagliflozin that reduce kidney disease progression by 30–40% regardless of diabetes status — a paradigm shift in nephrology), dietary protein moderation (0.6–0.8 g/kg/day in advanced CKD, though not restricting in early stages), sodium restriction (under 2,300 mg/day), and avoiding nephrotoxins — NSAIDs (ibuprofen, naproxen), excessive contrast dye, and certain herbal supplements. Regular exercise, smoking cessation, and maintaining a healthy BMI each independently reduce CKD progression risk.
GFR testing frequency depends on CKD stage: Stages 1–2 require annual monitoring, Stage 3a every 6 months, Stage 3b every 3–4 months, Stage 4 every 1–3 months, and Stage 5 monthly or more frequently. Each test should include a comprehensive metabolic panel (for electrolytes and bicarbonate), complete blood count (for anemia), urinalysis with albumin-to-creatinine ratio (for protein leak progression), and phosphorus and parathyroid hormone levels (starting at Stage 3b).
Many medications are cleared primarily through the kidneys, and dosing must be adjusted as GFR declines to prevent toxic accumulation. Common medications requiring renal dose adjustment include metformin (typically contraindicated below eGFR 30, dose-reduced between 30–45), gabapentin, pregabalin, certain antibiotics (vancomycin, gentamicin), digoxin, lithium, and direct oral anticoagulants like dabigatran and rivaroxaban. Over-the-counter medications also carry risk — regular NSAID use is a leading cause of preventable kidney damage, and even standard acetaminophen doses may need reduction in advanced CKD. Always verify medication safety at your current GFR level with your pharmacist or prescriber, especially when starting new medications or when your kidney function has changed since your last blood work.
Early detection and proactive management can dramatically slow CKD progression, preserving kidney function and delaying or preventing the need for dialysis by years or even decades.
See also: Blood Pressure Calculator · A1C Calculator · BMI Calculator
→ eGFR above 90 is normal; below 60 for 3+ months indicates CKD. A single low reading doesn't diagnose kidney disease — confirm with a repeat test. GFR naturally declines ~1 mL/min/year after age 40, so a 70-year-old with eGFR of 70 may be normal for age.
→ Creatinine is affected by muscle mass. Very muscular individuals may have elevated creatinine (low eGFR) without kidney disease. Very low muscle mass (elderly, malnourished) may show normal creatinine despite impaired kidney function. Cystatin C is an alternative biomarker less affected by muscle.
→ Hydration and protein intake affect results. Dehydration temporarily raises creatinine. A large steak dinner the night before testing can raise creatinine by 10–20%. Fast or eat normally before the test and avoid creatine supplements for 48 hours.
→ Kidney function determines drug dosing for many medications. Metformin, certain antibiotics, contrast dye protocols, and many other drugs require dose adjustment based on eGFR. Always inform your prescriber of your latest kidney function test. See our Medication Dosage Calculator.
See also: Medication Dosage · Blood Pressure · A1C Calculator · BMI Calculator